Michael Taylor, the manager of the Simplify Health Care ETF, is making waves in the investment world by not only delivering strong returns for investors but also giving back to a good cause. The ETF, which has grown to $136 million in assets in just two and a half years, donates all of its management fees to Susan G. Komen for the Cure to fund breast cancer research and support those affected by the disease.
Taylor’s unique approach to managing the fund has paid off, with the ETF outperforming its benchmark and attracting attention from investors. During an interview with MarketWatch, Taylor highlighted the fund’s top holdings and discussed a stock outside the healthcare sector that he believes has the potential for exponential returns.
One of the fund’s top holdings is Intuitive Surgical Inc., a company that Taylor believes is undervalued by analysts. He sees significant growth potential for the company as it plans to launch new robotic surgery equipment. Another key holding is Sarepta Therapeutics Inc., which is awaiting FDA approval for a new therapy for Duchenne muscular dystrophy.
In addition to healthcare stocks, Taylor is also eyeing opportunities outside the sector, such as PureCycle Technologies Inc., a company focused on recycling polypropylene. Taylor sees PureCycle as a potential “50-bagger” over the next decade, emphasizing the company’s unique position in the market.
Overall, Taylor’s idiosyncratic approach to managing the Simplify Health Care ETF has proven successful, with the fund delivering strong returns for investors while also supporting a worthy cause. As the fund continues to grow and attract attention, Taylor’s innovative investment strategies are sure to keep investors interested in the ever-evolving healthcare sector.
